Sensibilidade tuberculínica pós-vacinal e sua irrelevância para a revacinação BCG BCG induced tuberculin sensitivity and its irrelevance in revaccination

Sensibilidade tuberculínica pós-vacinal e sua irrelevância para a revacinação BCG BCG induced tuberculin sensitivity and its irrelevance in revaccination

Revisão realizada com o objetivo de mostrar que a prática de revacinar com BCG, baseada na negatividade do teste tuberculínico pós-vacinal, é destituída de fundamentos científicos. São apresentados alguns fatos nos quais se baseia o teste tuberculínico padronizado, seguidos de comentários sobre o pe...

Full description

Bibliographic Details
Main Author:	Gilberto Ribeiro Arantes
Format:	Article
Language:	English
Published:	Universidade de São Paulo 1980-06-01
Series:	Revista de Saúde Pública
Subjects:	Vacinação BCG Teste tuberculínico BCG vaccination Tuberculin test
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-89101980000200011

Similar Items

Reatividade tuberculínica e resposta imunológica celular e humoral "in vitro" em doentes com tuberculose pulmonar Delayed-type skin reaction to tuberculin and the cellular and humoral immune response "in vitro" in patients with pulmonary tuberculosis
by: Adele Caterino de Araújo, et al.
Published: (1983-04-01)

ANÁLISE COMPARATIVA NO PERFIL DA COBERTURA VACINAL DOS IMUNIZANTES BCG ENTRE AS CAPITAIS BRASILEIRAS NO PERÍODO DE 2018-2022
by: Thamires Souza Pires, et al.
Published: (2023-10-01)

Tuberculin conversion rate after BCG vaccination of apparently healthy infants in a resource-poor setting
by: Eziamaka J Enemuo, et al.
Published: (2022-01-01)

Modelo matemático para estimar impacto epidemiológico da vacinação BCG A mathematical model for estimating the effectiveness of BCG-vaccination
by: Antônio Ruffino-Netto, et al.
Published: (1977-12-01)

The safety of BCG revaccination in the context of COVID-19
by: Adriana Sánchez-García, et al.
Published: (2023-12-01)

Safety of BCG vaccination and revaccination in healthcare workers
by: Paola Villanueva, et al.
Published: (2023-08-01)

Genome sequences of BCG Pasteur ATCC 35734 and its derivative, the vaccine candidate BCGΔBCG1419c
by: Giuseppe D’Auria, et al.
Published: (2023-02-01)

IV BCG Vaccination and Aerosol BCG Revaccination Induce Mycobacteria-Responsive γδ T Cells Associated with Protective Efficacy against <i>M. tb</i> Challenge
by: Alexandra L. Morrison, et al.
Published: (2023-10-01)

BCG and Alternative Therapies to BCG Therapy for Non-Muscle-Invasive Bladder Cancer
by: Sarah Lidagoster, et al.
Published: (2024-02-01)

Diagnosis of latent tuberculosis infection in healthy young adults in a country with high tuberculosis burden and BCG vaccination at birth
by: Dagnew Alemnew F, et al.
Published: (2012-08-01)

Revisiting the Chingleput BCG vaccination trial for the impact of BCG revaccination on the incidence of tuberculosis disease
by: Banurekha Velayutham, et al.
Published: (2023-01-01)

BCG vaccination strategies against tuberculosis: updates and perspectives
by: Mengjin Qu, et al.
Published: (2021-12-01)

After 100 Years of BCG Immunization against Tuberculosis, What Is New and Still Outstanding for This Vaccine?
by: Mario Alberto Flores-Valdez
Published: (2021-12-01)

BCG in Bladder Cancer Immunotherapy
by: Song Jiang, et al.
Published: (2022-06-01)

Higher BCG‐induced trained immunity prevalence predicts protection from COVID‐19: Implications for ongoing BCG trials
by: Samer Singh, et al.
Published: (2022-06-01)

Frequency of absent BCG Scar in Babies Vaccinated with BCG
by: Aqeela Sami, et al.
Published: (2023-07-01)

BCG-SSI® vaccine-associated lymphadenitis: Incidence and management
by: Arnis Engelis, et al.
Published: (2016-01-01)

Um caso de adenite por BCG
by: Marta Sousa Tavares, et al.
Published: (2014-09-01)

Fighting Tuberculosis: In Search of a BCG Replacement
by: Nonna I. Nadolinskaia, et al.
Published: (2022-12-01)

An evaluation of the results of mantoux test in children received BCG vaccine during the neonatal period
by: M.H Daei-Parizi, et al.
Published: (2001-12-01)

Tuberculin Skin Test and CD4+/CD8+ T Cell Counts in Adults Infected with the Human Immunodeficiency Virus in Medellín, Colombia
by: JI Rodríguez, et al.
Published: (1997-03-01)

Auxotrophic <i>Mycobacterium bovis</i> BCG: Updates and Perspectives
by: Odir Antônio Dellagostin, et al.
Published: (2022-05-01)

Normas e Recomendações para o Emprego do BCG em Câncer
by: Humberto Torloni, et al.
Published: (2023-08-01)

Compared Efficacy of Adjuvant Intravesical BCG-TICE vs. BCG-RIVM for High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC): A Propensity Score Matched Analysis
by: Francesco Del Giudice, et al.
Published: (2022-02-01)

COVID-19 Infection and Previous BCG Vaccination Coverage in the Ecuadorian Population
by: Daniel Garzon-Chavez, et al.
Published: (2021-01-01)

Miliary Tuberculosis Due to BCG Immunotherapy
by: Bilgehan AYGEN, et al.
Published: (1996-03-01)

Two cases of disseminated BCG disease following vaccination in the same family: case reports and review of the literature in China
by: Jing Wang, et al.
Published: (2021-05-01)

Vascular graft infections caused by Mycobacterium bovis BCG after BCG immunotherapy for non-muscle-invasive bladder cancer: Case report and review of literature
by: Stefania Arsuffi, et al.
Published: (2023-05-01)

Specifics, character and basic approaches to the treatment of complications of BCG vaccination
by: N. A. Matsehora, et al.
Published: (2018-10-01)

Complete Genome Sequence, Genome Stability and Phylogeny of the Vaccine Strain <i>Mycobacterium bovis</i> BCG SL222 Sofia
by: Stefan Panaiotov, et al.
Published: (2021-03-01)

Immunogenicity and Protection against <i>Mycobacterium caprae</i> Challenge in Goats Vaccinated with BCG and Revaccinated after One Year
by: Claudia Arrieta-Villegas, et al.
Published: (2020-12-01)

Factors influencing scar formation following Bacille Calmette-Guérin (BCG) vaccination
by: Paola Villanueva, et al.
Published: (2023-04-01)

Systematic Review and Meta-Analysis of Response Rates in BCG-unresponsive Non–Muscle-Invasive Bladder Cancer: a Consensus Statement From the International Bladder Cancer Group
by: Kyle M. Rose, et al.
Published: (2022-09-01)

Grupo Técnico de Estudos do BCG em Câncer Vacina BCG (Bacillus Calmette-Guérin)
by: Humberto Torloni, et al.
Published: (2023-08-01)

A case of disseminated M. bovis bacillus Calmette-Guérin (BCG) disease after one month of BCG bladder infusion therapy and analysis of 77 cases of suspected BCG infection in Japan, 2017–2022
by: Masashi Nishimura, et al.
Published: (2023-01-01)

Perbandingan Keamanan dan Konversi Tuberkulin dari Vaksin BCG Strain Moskow dan Vaksin BCG Strain Pasteur pada Bayi
by: Ni Putu Siadi Purniti, et al.
Published: (2016-11-01)

REAÇÃO ADVERSA À VACINA BCG EM LACTENTE
by: Edson Santana Gois Filho, et al.
Published: (2023-10-01)

Pott's disease post intravesical BCG
by: Anika Jain
Published: (2023-01-01)

Grupo Técnico de Estudos do BCG em Câncer: julho de 1976: Rio de Janeiro - Brasil
by: Humberto Torloni
Published: (2023-08-01)

Influência do BCG no controle da imunodeficiência humoral induzida pelo mastocitoma P-815 Influence of BCG in the control of humoral deficiency induced by mastocytoma P-815
by: H. M. Bräscher, et al.
Published: (1986-06-01)